Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

Clinical trial NCT01284517 · COMPLETED

Trial details

NCT number: NCT01284517
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression

Start date: 2010-11-01
Primary completion: 2012-08-01
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.